Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
2023 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (57)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (22)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (308)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (11)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (31)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (139)
University of California, San Francisco (125)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (723)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (319)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (302)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (132)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (346)
Closed (1110)
Pre-Active (25)
Institution
Researcher name
Grant Type
Grant Title
Award Value
University of California, San Francisco
Dr. Robert Blelloch Dr.
New Faculty II
Mechanisms of small RNA regulation in early embryonic development
$2,790,695
University of California, Los Angeles
Dr. Antoni Ribas MD/PhD
New Faculty II
Stem Cells for Immune System Regeneration to Fight Cancer
$3,072,000
San Diego State University Foundation
Dr. Ricardo M. Zayas
New Faculty II
The molecular basis underlying adult neurogenesis during regeneration and tissue renewal
$1,712,225
University of Southern California
Dr. Qilong Ying
New Faculty II
Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation
$2,261,174
University of California, San Diego
Dr. Benjamin D. Yu
New Faculty II
Regulation of Adult Stem Cell Proliferation by RAS and Cell-Permeable Proteins
$3,017,978
University of California, San Diego
Dr. Shyni Varghese
New Faculty II
A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment
$2,300,569
University of California, San Francisco
Dr. Holger F Willenbring
New Faculty II
Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells
$2,832,008
Children’s Hospital of Los Angeles
Dr. Tracy Cannon Grikscheit M.D.
New Faculty II
Mechanism of Tissue Engineered Small Intestine Formation
$3,211,122
University of California, San Diego
Dr. Mana M Parast
New Faculty II
Molecular Mechanisms of Trophoblast Stem Cell Specification and Self-Renewal
$3,077,918
University of Southern California
Dr. Gage Crump
New Faculty II
Skeletogenic Neural Crest Cells in Embryonic Development and Adult Regeneration of the Jaw
$2,247,403
University of California, San Diego
Catriona Jamieson
New Faculty II
Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells
$3,065,572
Stanford University
Dr. Ching-Pin Chang
New Faculty II
VEGF signaling in adventitial stem cells in vascular physiology and disease
$3,005,695
Ludwig Institute for Cancer Research
Dr. Bing Ren
New Faculty II
Mechanisms of chromatin dynamics at enhancers during ES cell differentiation
$1,726,564
University of California, Los Angeles
Dr. Brigitte N Gomperts
New Faculty II
Stem Cells in Lung Cancer
$2,381,572
University of California, Davis
Dr. Paul S. Knoepfler
New Faculty II
Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency
$2,157,255
University of California, San Francisco
Dr. Jeremy Reiter
New Faculty II
High throughput modeling of human neurodegenerative diseases in embryonic stem cells
$2,259,092
Gladstone Institutes, J. David
Dr. Benoit Bruneau
New Faculty II
Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors
$2,723,653
Sanford Burnham Prebys Medical Discovery Institute
Dr. Zhuohua Zhang
New Cell Lines
Derivation of Parkinson’s Disease Coded-Stem Cells (PD-SCs)
$1,556,448
University of California, Los Angeles
Dr. Jerome A. Zack Ph.D.
New Cell Lines
Generation of clinical grade human iPS cells
$1,341,000
Stanford University
Dr. Renee Reijo Pera PhD
New Cell Lines
Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype
$1,409,243
University of Southern California
Dr. Martin Pera
New Cell Lines
New Technology for the Derivation of Human Pluripotent Stem Cell Lines for Clinical Use
$1,266,134
Stanford University
Michael T. Longaker M.D.
New Cell Lines
Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts
$1,406,636
Stanford University
Dr. Julie Baker
New Cell Lines
Derivation of hESC Lines with Disease Lesions
$1,404,725
Scripps Research Institute
Dr. Sheng Ding Dr.
New Cell Lines
Derivation of New ICM-stage hESCs
$936,973
Gladstone Institutes, J. David
Sheng Ding PhD
New Cell Lines
Derivation of New ICM-stage hESCs
$778,859
Gladstone Institutes, J. David
Dr. Bruce R. Conklin
New Cell Lines
Induced Pluripotent Stem Cells for Cardiovascular Diagnostics
$1,708,560
Stanford University
Dr. Michele Calos
New Cell Lines
Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses
$1,406,875
University of California, San Francisco
Dr. Susan J Fisher PhD
New Cell Lines
Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines
$1,383,419
University of California, San Francisco
Dr. Miguel Ramalho-Santos
New Cell Lines
Somatic cell age and memory in the generation of iPS cells
$1,307,201
University of California, San Francisco
Dr. Long-cheng Li
New Cell Lines
Induction of pluripotent stem cells by small RNA-guided transcriptional activation
$1,368,461
Gladstone Institutes, J. David
Robert V Farese
New Cell Lines
Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations
$1,696,424
Salk Institute for Biological Studies
Dr. Fred H Gage
New Cell Lines
Development of Induced Pluripotent Stem Cells for Modeling Human Disease
$1,737,720
University of California, Los Angeles
Dr. Amander Clark Dr.
New Cell Lines
Generation of Pluripotent Cell Lines from Human Embryos
$1,167,416
University of California, Irvine
Dr. Leslie M Thompson
New Cell Lines
New Cell Lines for Huntington’s Disease
$1,302,526
University of California, San Diego
Dr. Steven F Dowdy
New Cell Lines
Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin.
$1,073,585
University of California, Davis
Dr. Mark Zern
Comprehensive Grant
An in vitro and in vivo comparison among three different human hepatic stem cell populations.
$2,251,223
Stanford University
Professor Irving L Weissman MD
Comprehensive Grant
Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells
$2,471,386
University of California, San Francisco
Dr. Andrew D. Leavitt MD
Comprehensive Grant
Understanding hESC-based Hematopoiesis for Therapeutic Benefit
$2,460,822
University of California, Irvine
Dr Hans S Keirstead
Comprehensive Grant
hESC-Derived Motor Neurons For the Treatment of Cervical Spinal Cord Injury
$2,158,445
University of California, Los Angeles
Dr. Jerome A. Zack Ph.D.
Comprehensive Grant
Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease
$2,401,903
University of California, San Diego
Dr. Yang Xu
Comprehensive Grant
Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells
$2,467,200
University of California, Davis
Dr. Alice F Tarantal
Comprehensive Grant
Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells
$2,166,757
Sanford Burnham Prebys Medical Discovery Institute
Dr. Stuart A Lipton
Comprehensive Grant
MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells
$2,832,000
Stanford University
Dr. Stefan Heller
Comprehensive Grant
Generation of inner ear sensory cells from human ES cells toward a cure for deafness
$2,330,371
University of California, Irvine
Dr. Peter John Donovan
Comprehensive Grant
Improved hES Cell Growth and Differentiation
$2,381,713
Children’s Hospital of Los Angeles
Dr. Gay M. Crooks
Comprehensive Grant
Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC)
$575,994
University of California, Los Angeles
Dr. Gay Miriam Crooks
Comprehensive Grant
Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC)
$1,653,416
University of California, San Francisco
Dr. Samuel Pleasure
Comprehensive Grant
Human stem cell derived oligodendrocytes for treatment of stroke and MS
$2,459,235
University of California, San Francisco
Dr. Harold S Bernstein Dr.
Comprehensive Grant
Modeling Myocardial Therapy with Human Embryonic Stem Cells
$2,134,694
Stanford University
Dr. Roel Nusse
Comprehensive Grant
Guiding the developmental program of human embryonic stem cells by isolated Wnt factors
$1,710,462
« Previous
1
…
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Next »